Women’s Heart Health Expansion Act of 2026

This Act may be cited as the Women’s Heart Health Expansion Act of 2026.

Section 1509 of the Public Health Service Act (42 U.S.C. 300n–4a) is amended to read as follows:

The Secretary, acting through the Director of the Centers for Disease Control and Prevention, may award supplemental grants to recipients of grants under section 1501 to carry out projects for the purposes of—

(1) providing preventive health services in addition to the services authorized in such section, including—

(A) screenings regarding blood pressure, cholesterol, obesity, and other relevant risk factors; and

(B) evidence-based health education offered by a qualified provider to improve a measurable health outcome, such as blood pressure, cholesterol, diabetes, or obesity;

(2) providing appropriate referrals for medical treatment of women receiving services pursuant to paragraph (1) and ensuring, to the extent practicable, the provision of appropriate follow-up services; and

(3) evaluating activities conducted under paragraphs (1) and (2) through appropriate surveillance or program-monitoring activities and reporting to the Secretary on such activities.

Women eligible for services pursuant to a grant under subsection (a) shall include—

(1) women eligible for services pursuant to a grant made under section 1501; and

(2) other women who are high-risk and meet such eligibility criteria as the Secretary may specify.

Health services provided pursuant to a grant under subsection (a) shall be provided by—

(1) an entity screening women for breast and cervical cancer pursuant to a grant under section 1501; or

(2) other health care entities, as the Secretary determines.

To carry out this section, there is authorized to be appropriated $250,000,000 for the period of fiscal years 2027 through 2031.

.

Not later than September 30, 2027, the Comptroller General of the United States shall report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives on the work of the Well-Integrated Screening and Evaluation for Women Across the Nation Program, including—

(1) an estimate of the number of individuals eligible for services provided under such program;

(2) a summary of trends in the number of individuals served through such program;

(3) an assessment of any factors that may be driving the trends identified under paragraph (2), including any barriers to accessing cardiovascular health screenings provided by such program; and

(4) an analysis of the cost-effectiveness of such program with respect to patient outcomes, such as blood pressure, cholesterol, diabetes, or obesity.